Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease -: A matched case-control study

被引:232
作者
Schwedhelm, E
Bartling, A
Lenzen, H
Tsikas, D
Maas, R
Brümmer, J
Gutzki, FM
Berger, J
Frölich, JC
Böger, RH
机构
[1] Univ Hamburg, Hosp Eppendorf, Inst Expt & Klin Pharmakol, Clin Pharmacol Unit, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Inst Clin Chem, D-20246 Hamburg, Germany
[3] Univ Hamburg, Hosp Eppendorf, Inst Math & Data Proc Med, D-20246 Hamburg, Germany
[4] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany
关键词
prostaglandins; coronary disease; C-reactive protein; isoprostanes; risk factors;
D O I
10.1161/01.CIR.0000116761.93647.30
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Oxidative stress is involved in the pathophysiology of atherosclerosis, diabetes mellitus, hypertension, obesity, and cigarette smoking, all of these being risk factors for coronary heart disease (CHD). We tested the hypothesis that risk factors of CHD are associated with abundant systemic oxidative stress. Methods and Results - We conducted a case-control study with 93 CHD patients and 93 control subjects frequency-matched by age and sex. Urinary excretion of the F-2-isoprostane 8-iso-prostaglandin (PG) F-2alpha and its major urinary metabolite, 2,3-dinor-5,6-dihydro-8-iso-PGF(2alpha), were measured by gas chromatography - tandem mass spectrometry. Body mass index, systolic blood pressure, and C-reactive protein were elevated in CHD patients ( P < 0.01). Urinary 8-iso-PGF(2α) and 2,3-dinor-5,6-dihydro-8-iso-PGF(2α) also differed, from 77 (interquartile range, 61 - 101) to 139 ( 93 - 231) pmol/mmol creatinine and from 120 (91 - 151) to 193 (140 - 275) pmol/mmol in control subjects and case subjects, respectively (P < 0.001). 8-iso-PGF(2alpha) and its metabolite were highly correlated (Spearman's rho = 0.664, P < 0.001). HDL cholesterol was diminished in CHD patients ( P < 0.001). All of these characteristics predicted CHD in univariate analysis. In a multivariate model, the odds ratios were increased only for 8-iso-PGF(2alpha) (greater than or equal to131 pmol/mmol, P < 0.001) and C-reactive protein (>3 mg/ L, P < 0.01), ie, by 30.8 (95% CI, 7.7 - 124) and 7.2 (1.9 - 27.6), respectively. 8-iso-PGF(2α) was found to be a novel marker in addition to known risk factors of CHD, ie, diabetes mellitus, hypercholesterolemia, hypertension, and smoking. Urinary excretion of 8-iso-PGF(2α) correlated with the number of risk factors for all subjects ( P < 0.001 for trend). Conclusions - 8-iso-PGF(2alpha) is a sensitive and independent risk marker of CHD.
引用
收藏
页码:843 / 848
页数:6
相关论文
共 29 条
  • [21] The isoprostanes: Their quantification as an index of oxidant stress status in vivo
    Morrow, JD
    [J]. DRUG METABOLISM REVIEWS, 2000, 32 (3-4) : 377 - 385
  • [22] Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
    Ridker, PM
    Rifai, N
    Rose, L
    Buring, JE
    Cook, NR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) : 1557 - 1565
  • [23] Mechanisms of disease - Atherosclerosis - An inflammatory disease
    Ross, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) : 115 - 126
  • [24] Tandem mass spectrometric quantification of 8-iso-prostaglandin F2α and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2α in human urine
    Schwedhelm, E
    Tsikas, D
    Durand, T
    Gutzki, FM
    Guy, A
    Rossi, JC
    Frölich, JC
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 744 (01): : 99 - 112
  • [25] Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy
    Shishehbor, MH
    Aviles, RJ
    Brennan, ML
    Fu, XM
    Goormastic, M
    Pearce, GL
    Gokce, N
    Keaney, JF
    Penn, MS
    Sprecher, DL
    Vita, JA
    Hazen, SL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (13): : 1675 - 1680
  • [26] Therond P, 2000, Curr Opin Clin Nutr Metab Care, V3, P373, DOI 10.1097/00075197-200009000-00009
  • [27] Specific and rapid quantification of 8-iso-prostaglandin F2α in urine of healthy humans and patients with Zellweger syndrome by gas chromatography tandem mass spectrometry
    Tsikas, D
    Schwedhelm, E
    Fauler, J
    Gutzki, FM
    Mayatepek, E
    Frölich, JC
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1998, 716 (1-2): : 7 - 17
  • [28] Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease
    Vassalle, C
    Botto, N
    Andreassi, MG
    Berti, S
    Biagini, A
    [J]. CORONARY ARTERY DISEASE, 2003, 14 (03) : 213 - 218
  • [29] Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
    Watson, AD
    Leitinger, N
    Navab, M
    Faull, KF
    Horkko, S
    Witztum, JL
    Palinski, W
    Schwenke, D
    Salomon, RG
    Sha, W
    Subbanagounder, G
    Fogelman, AM
    Berliner, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) : 13597 - 13607